Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.

MLA

Gaig, Carles, et al. “Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.” Neurology, vol. 102, no. 7, Apr. 2024, p. e208101. EBSCOhost, https://doi.org/10.1212/WNL.0000000000208101.

APA

Gaig, C., Grüter, T., Heidbreder, A., Sabater, L., Iranzo, A., Santamaria, J., Leypoldt, F., Dalmau, J. O., Ayzenberg, I., & Graus, F. (2024). Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease. Neurology, 102(7), e208101. https://doi.org/10.1212/WNL.0000000000208101

Chicago

Gaig, Carles, Thomas Grüter, Anna Heidbreder, Lidia Sabater, Alex Iranzo, Joan Santamaria, Frank Leypoldt, Josep O Dalmau, Ilya Ayzenberg, and Francesc Graus. 2024. “Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.” Neurology 102 (7): e208101. doi:10.1212/WNL.0000000000208101.